Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the globe. It is
associated with significant mortality, particularly in at-risk groups with poor prognostic …

Coagulopathy in coronavirus infection has been shown to be associated with high mortality
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …

The coagulopathy caused by SARS-CoV-2 seen in patients hospitalised with COVID-19,
especially those with severe or critical illness, is by now well established. Early reports in …

We congratulate Giacomo Grasselli and colleagues for their important and informative work
on the pathophysiology of COVID-19-associated acute respiratory distress syndrome …

The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2
and is characterized by an exaggerated inflammatory response that can lead to severe …

Recent data have shown that coagulation activation is common in patients with severe
COVID-19. 1, 2 Moreover, autopsy studies have reported widespread microthrombi …

The lung pathology seen in patients with coronavirus disease 2019 (COVID-19) shows
marked microvascular thrombosis and haemorrhage linked to extensive alveolar and …

The systematic review and metaanalysis of interleukin (IL)-6 in COVID-19, by Daniel
Leisman and colleagues, 1 provides a crucial comparison with other inflammatory …

April 16, 2021 https://doi. org/10.1016/S2213-2600 (21) 00168-5 scaffold for intravascular
thrombus formation. It might also cause thrombotic microangiopathy in the microvasculature …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for
coronavirus disease 2019 (COVID-19). Recent data highlight a pivotal role for pulmonary …